Literature DB >> 15638159

Chromatographic methods for the separation of biocompatible iron chelators from their synthetic precursors and iron chelates.

Petra Kovaríková1, Milan Mokrý, Jirí Klime, Katerina Vávrová.   

Abstract

Chromatographic methods have been developed for the separation of the three novel biocompatible iron chelators pyridoxal isonicotinoyl hydrazone (PIH), salicylaldehyde isonicotinoyl hydrazone (SIH), and pyridoxal 2-chlorobenzoyl hydrazone (o-108) from their synthetic precursors and iron chelates. The chromatographic analyses were achieved using analytical columns packed with 5 microm Nucleosil 120-5 C18. For the evaluation of all chelators in the presence of the synthetic precursors, EDTA was added to the mobile phase at a concentration of 2 mM. The best separation of PIH and its synthetic precursors was achieved using a mixture of phosphate buffer (0.01 M NaH2PO4, 5 mM 1-heptanesulfonic acid sodium salt; pH 3.0) and methanol (55:45, v/v). For separation of SIH and its synthetic precursors, the mobile phase was composed of 0.01 M phosphate buffer (pH 6.0) and methanol (60:40, v/v). o-108 was analyzed employing a mixture of 0.01 M phosphate buffer (pH 7.0), methanol, and acetonitrile (60:20:20, v/v/v). These mobile phases were slightly modified to separate each chelator from its iron chelate. Furthermore, a RP-TLC method has also been developed for fast separation of all compounds. The chromatographic methods described herein could be applied in the evaluation of purity and stability of these drug candidates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15638159     DOI: 10.1002/jssc.200401878

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  2 in total

1.  LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH).

Authors:  Jan Bureš; Hana Jansová; Ján Stariat; Tomáš Filipský; Přemysl Mladěnka; Tomáš Šimůnek; Radim Kučera; Jiří Klimeš; Qin Wang; Katherine J Franz; Petra Kovaříková
Journal:  J Pharm Biomed Anal       Date:  2014-12-03       Impact factor: 3.935

2.  Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.

Authors:  T Simůnek; M Sterba; O Popelová; H Kaiserová; M Adamcová; M Hroch; P Hasková; P Ponka; V Gersl
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.